Vuong Trieu - 31 Mar 2021 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Vuong Trieu
Issuer symbol
OTLC
Transactions as of
31 Mar 2021
Net transactions value
$0
Form type
4
Filing time
16 Jul 2021, 17:38:27 UTC
Next filing
08 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Conversion of derivative security +74,455,719 +471% 90,268,021 31 Mar 2021 Direct F1
transaction OTLC Common Stock Award $0 +259,302 +0.29% $0.000000 90,527,323 08 Jul 2021 Direct F2
transaction OTLC Common Stock Conversion of derivative security +13,849,161 +472% 16,780,384 31 Mar 2021 By Autotelic, Inc. F1
transaction OTLC Common Stock Conversion of derivative security +5,672,025 +472% 6,872,529 31 Mar 2021 By Spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTLC Series A Convertible Preferred Stock Conversion of derivative security -74,456 -100% 0 31 Mar 2021 Common Stock 74,455,719 Direct F1, F3
transaction OTLC Series A Convertible Preferred Stock Conversion of derivative security -13,849 -100% 0 31 Mar 2021 Common Stock 13,849,161 By Autotelic, Inc. F1, F3
transaction OTLC Series A Convertible Preferred Stock Conversion of derivative security -5,672 -100% 0 31 Mar 2021 Common Stock 5,672,025 By Spouse F1, F3
transaction OTLC Stock Options Award $0 +513,953 $0.000000 513,953 08 Jul 2021 Common Stock 513,953 $0.1626 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Agreement and Plan of Merger dated April 17, 2019, between the Issuer and Oncotelic, Inc., shares of the Issuer's Series A Convertible Preferred Stock ("Series A Preferred") held by the reporting person converted into shares of the Issuer's common stock, following a recapitalization by the Issuer.
F2 Shares were issued in settlement of Restricted Stock Units granted pursuant to the Issuer's 2015 Equity Incentive Plan that vested immediately upon grant.
F3 Shares of the Series A Convertible Preferred Stock does not expire.
F4 Stock options granted pursuant to the Issuer's 2015 Equity Incentive Plan and which vest immediately on the date of grant.